Breast Cancer Trial, Recruiting (NCT07546331)

Breast Cancer Trial, Recruiting NCT07546331 Sponsor: University of California, San Francisco Condition: Breast Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT07546331 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Breast Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have been diagnosed with breast cancer (confirmed by lab testing), or who have been identified as having a higher-than-normal risk of developing breast cancer.
People who are 18 years of age or older.
People who are scheduled to have a mastectomy followed immediately by breast reconstruction, using either an implant, a tissue expander, or the person's own body tissue (such as a DIEP flap, msTRAM flap, or PAP flap procedure).
People who are able to understand and willing to sign a written consent form.

Who may not be able to join:

People who have a significant medical condition or abnormal test results that the trial site determines would make participation unsafe.
People who are currently pregnant or breastfeeding.
People who were assigned male at birth.
People who are not cisgender women (confirm with trial site for clarification on this criterion).
People who have an implanted electronic medical device, such as a pacemaker or defibrillator.
People who have a prosthetic limb.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Merisas Piper, MD, University of California, San Francisco

Phone: 877-827-3222

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07546331

Sponsor: University of California, San Francisco

Phase: Not Applicable

Status: Recruiting

Condition: Breast Cancer

Trial contact: 877-827-3222

More information: https://clinicaltrials.gov/study/NCT07546331

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have been diagnosed with breast cancer (confirmed by lab testing), or who have been identified as having a higher-than-normal risk of developing breast cancer.
People who are 18 years of age or older.
People who are scheduled to have a mastectomy followed immediately by breast reconstruction, using either an implant, a tissue expander, or the person's own body tissue (such as a DIEP flap, msTRAM flap, or PAP flap procedure).
People who are able to understand and willing to sign a written consent form.

Who may not be able to join:

People who have a significant medical condition or abnormal test results that the trial site determines would make participation unsafe.
People who are currently pregnant or breastfeeding.
People who were assigned male at birth.
People who are not cisgender women (confirm with trial site for clarification on this criterion).
People who have an implanted electronic medical device, such as a pacemaker or defibrillator.
People who have a prosthetic limb.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of California, San Francisco

Registry

ClinicalTrials.gov

Start date

18 February 2026

Est. completion

31 December 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Proportion of Body Composition Measurement Collection

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov